KCNMA1 Gene Generalized epilepsy and paroxysmal dyskinesia Genetic Test
At DNA Labs UAE, we offer the KCNMA1 Gene Generalized epilepsy and paroxysmal dyskinesia Genetic Test at a cost of AED 4400.0. This test is used to diagnose and analyze the KCNMA1 gene for mutations and variants that may contribute to the development of generalized epilepsy and paroxysmal dyskinesia (GEPD).
Test Components
- Price: AED 4400.0
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery
The report for the KCNMA1 Gene Generalized epilepsy and paroxysmal dyskinesia Genetic Test will be delivered within 3 to 4 weeks.
Method
The test is conducted using NGS (Next-Generation Sequencing) technology.
Test Type
The KCNMA1 Gene Generalized epilepsy and paroxysmal dyskinesia Genetic Test falls under the category of Neurological Disorders.
Doctor
This test is recommended by Neurologists.
Test Department
The KCNMA1 Gene Generalized epilepsy and paroxysmal dyskinesia Genetic Test is conducted in our Genetics department.
Pre Test Information
Prior to the test, it is important to provide the clinical history of the patient who is undergoing the KCNMA1 Gene Generalized epilepsy and paroxysmal dyskinesia NGS Genetic DNA Test. A Genetic Counselling session is also recommended to draw a pedigree chart of family members affected with KCNMA1 Gene Generalized epilepsy and paroxysmal dyskinesia.
Test Details
The KCNMA1 gene is associated with a rare genetic disorder known as generalized epilepsy and paroxysmal dyskinesia (GEPD). Individuals with GEPD experience recurrent episodes of seizures and involuntary movements, including dystonia, chorea, and myoclonus.
NGS genetic testing is used to analyze the KCNMA1 gene for mutations and variants that may contribute to the development of GEPD. This type of testing can help diagnose GEPD and guide treatment decisions. However, it is important to note that genetic testing is not always necessary or appropriate for all individuals with GEPD. A healthcare provider, particularly a Neurologist, can help determine if genetic testing is suitable based on the patient’s medical history, symptoms, and other factors.
Test Name | KCNMA1 Gene Generalized epilepsy and paroxysmal dyskinesia Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for KCNMA1 Gene Generalized epilepsy and paroxysmal dyskinesia NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with KCNMA1 Gene Generalized epilepsy and paroxysmal dyskinesia |
Test Details |
The KCNMA1 gene is associated with a rare genetic disorder known as generalized epilepsy and paroxysmal dyskinesia (GEPD). GEPD is characterized by recurrent episodes of seizures and involuntary movements, including dystonia, chorea, and myoclonus. NGS (Next-Generation Sequencing) genetic testing can be used to analyze the KCNMA1 gene for mutations and variants that may contribute to the development of GEPD. This type of testing can help diagnose GEPD and guide treatment decisions. However, it is important to note that genetic testing is not always necessary or appropriate for all individuals with GEPD. A healthcare provider can help determine if genetic testing is appropriate for a particular patient based on their medical history, symptoms, and other factors. |